🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the addition of budesonid...
Status
Completed
Location
Children's Hospital of Philadelphia Emergency Department
Start Date
2006-12
Trial ID
NCT00393367
This is a pilot study to investigate the effect of danirixin hydrobromide 3...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-10-16
Trial ID
NCT03170232
Treatments Being Tested
Study to demonstrate that at least one of the two doses of Berodual® (50 µg...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02182505
Treatments Being Tested
The objective of this study was to compare the bronchodilator efficacy and ...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02260011
Treatments Being Tested
Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratr...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT02172781
To determine whether addition of ipratropium bromide to salbutamol nebulisa...
Status
Terminated
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02235428
Treatments Being Tested
This study has the objective to clarify the factors that directly influence...
Status
Completed
Location
Universidade Federal de Pernambuco
Start Date
2017-12-02
Trial ID
NCT03031093
Treatments Being Tested
Study to assess the safety of two-week administration of 80 and 160 mcg of ...
Status
Completed
Location
Multiple Locations
Start Date
1998-07
Trial ID
NCT02236182
Treatments Being Tested
The objective of this study is to confirm that chronic dosing of 20 mcg and...
Status
Completed
Location
Multiple Locations
Start Date
1998-08
Trial ID
NCT02177344
Treatments Being Tested
To demonstrate that at least one of the two doses of Berodual® (50 µg fenot...
Status
Completed
Location
Multiple Locations
Start Date
1998-02
Trial ID
NCT02173782
Treatments Being Tested